發(fā)布時(shí)間：2018-03-05 06:49

  本文選題：惡性腫瘤　切入點(diǎn)：胸腔積液　出處：《吉林大學(xué)》2015年碩士論文　論文類型：學(xué)位論文

【摘要】：目的： 探討肺癌所致胸腔積液的診斷及治療。 方法： 在2014年3月-2015年3月我科收治的胸腔積液病人中篩選出肺癌所致胸腔積液患者86名，經(jīng)檢查，診斷，治療及動(dòng)態(tài)療效觀察，對(duì)比不同年齡、不同性別、不同部位、不同病理類型和組織類型肺癌患者胸腔積液的發(fā)病率和治療效果。利用統(tǒng)計(jì)學(xué)方法進(jìn)行分析�？偨Y(jié)出肺癌引起胸腔積液的臨床特點(diǎn)，為此類病患的診治提供借鑒。 結(jié)果： 一般資料比較：患者年齡、性別、一般狀態(tài)、肺癌的類型、肺癌的部位、肺癌大小等，經(jīng)過比較究結(jié)果表明：肺癌患者中腺癌產(chǎn)生胸腔積液明顯多于其他細(xì)胞類型；周圍型肺癌患者胸腔積液產(chǎn)生明顯多于中心型肺癌患者；與肺癌大小無關(guān)。年齡、性別等情況對(duì)肺癌患者胸腔積液的產(chǎn)生影響不大。肺癌所致胸腔積液胸腔引流后胸腔注射胸膜粘連劑，，使胸腔積液的復(fù)發(fā)率明顯降低。所以胸膜粘連劑在治療肺癌所致胸腔積液中起到較明顯效果，值得推廣使用。在其他原因引起的反復(fù)性胸腔積液中也可以考慮應(yīng)用胸膜粘連劑，尤其惡性腫瘤原因引起的胸腔積液。 結(jié)論： 惡性胸腔積液是惡性腫瘤胸膜轉(zhuǎn)移的結(jié)果。通過胸部X線片、胸部CT、胸腔超聲檢查、診斷性試穿可明確胸腔積液的診斷。細(xì)胞學(xué)檢查發(fā)現(xiàn)肺癌細(xì)胞可明確肺癌所致胸腔積液的診斷�；颊呷缒茉缙诘玫酱_診，并進(jìn)行積極正確的治療,延長患者生存時(shí)間,提高患者的生存質(zhì)量是可以實(shí)現(xiàn)的。目前對(duì)惡性胸腔積液的治療包括胸腔引流，胸膜粘連等方法仍然是治療胸腔積液的最有效的方法，但不能使惡性腫瘤本身得到控制。
[Abstract]:Objective:. To investigate the diagnosis and treatment of pleural effusion caused by lung cancer. Methods:. From March 2014 to March 2015, 86 patients with pleural effusion caused by lung cancer were selected from our department. The incidence and therapeutic effect of pleural effusion in lung cancer patients with different pathological types and tissue types were analyzed by statistical method. The clinical characteristics of pleural effusion caused by lung cancer were summarized, which provided a reference for the diagnosis and treatment of lung cancer patients. Results:. Comparison of general data: age, sex, general state, type of lung cancer, location of lung cancer, size of lung cancer, etc. The results showed that adenocarcinoma produced more pleural effusion than other cell types in patients with lung cancer. The pleural effusion in patients with peripheral lung cancer was significantly higher than that in patients with central lung cancer; it had nothing to do with the size of lung cancer. Sex has little effect on pleural effusion in patients with lung cancer. After pleural drainage, pleural adhesives were injected into the pleural cavity of lung cancer patients. The recurrence rate of pleural effusion was obviously reduced. Therefore, pleural adhesives have obvious effect in treating pleural effusion caused by lung cancer, and are worth popularizing. Pleural adhesives can also be considered in recurrent pleural effusion caused by other reasons. Especially the pleural effusion caused by malignant tumor. Conclusion:. Malignant pleural effusion is the result of pleural metastasis of malignant tumor. The diagnostic test can confirm the diagnosis of pleural effusion. Cytological examination shows that lung cancer cells can confirm the diagnosis of pleural effusion caused by lung cancer. If the patient can be diagnosed at an early stage and receive positive and correct treatment to prolong the survival time of the patient, At present, the treatment of malignant pleural effusion, including pleural drainage and pleural adhesion, is still the most effective method for the treatment of pleural effusion, but the malignant tumor itself cannot be controlled.
【學(xué)位授予單位】：吉林大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類號(hào)】：R734.2

【參考文獻(xiàn)】

相關(guān)期刊論文 前8條

1 Kuang-Rong Wei;Xia Yu;Rong-Shou Zheng;Xia-Biao Peng;Si-Wei Zhang;Ming-Fang Ji;Zhi-Heng Liang;Zhi-Xiong Ou;Wan-Qing Chen;;Incidence and mortality of liver cancer in China, 2010[J];Chinese Journal of Cancer;2014年08期

2 王彩英;張映銘;;洛鉑聯(lián)合足葉乙甙治療晚期小細(xì)胞肺癌的臨床研究[J];臨床肺科雜志;2009年08期

3 楊柳青;秦叔逵;;第3代鉑類藥物洛鉑的研究新進(jìn)展[J];臨床腫瘤學(xué)雜志;2009年12期

4 郝可可;朱際平;于力克;;Survivin檢測(cè)在肺癌胸腔積液診斷中的臨床價(jià)值[J];山東大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2010年12期

5 趙昌林;程少冰;李恒謀;;惡性腫瘤放化療對(duì)機(jī)體損傷的病因病機(jī)分析[J];山東中醫(yī)雜志;2010年01期

6 歐紅萍;周鳳勤;;超聲在胸腔積液診斷中的應(yīng)用價(jià)值[J];臨床和實(shí)驗(yàn)醫(yī)學(xué)雜志;2013年14期

7 劉粉霞;;中心靜脈導(dǎo)管在惡性胸腔積液治療中的應(yīng)用[J];現(xiàn)代腫瘤醫(yī)學(xué);2014年01期

8 廉政君;黃建國;;晚期非小細(xì)胞肺癌預(yù)后相關(guān)因素分析[J];現(xiàn)代腫瘤醫(yī)學(xué);2014年01期

本文編號(hào)：1569182